FOCIS 2022 Award Recipients

FOCIS2022 LOGO 4004x1468 01

Award Recipients

FOCIS is proud to announce the awards recipients below. They will be recognized at the FOCIS Annual Meeting.

Congratulations to the nominees and recipients for their achievements!

Elsevier 2019 logo

Clinical Immunology Award

Together with FOCIS, Clinical Immunology is pleased to provide this award to a colleague in training (student or fellow) who is the presenting author of an abstract submitted for presentation at the FOCIS 2022 Annual Meeting. Clinical Immunology Trainee Award recipients are eligible to receive up to $2,500 to cover expenses related to their meeting participation.

Al Eryani Ghamdan 2022

2022 Recipient

Ghamdan Al-Eryani, PhD, Garvan Institute, Sydney, Australia
Abstract (Immuno-oncology)
Th47 – Single Cell and Spatially Resolved Analysis of Tissues by Integrated RNA and Protein Multi-omics Identifies Novel Tumour-infiltrating Lymphocyte Phenotypes

CGFFF logo med

C. Garrison Fathman Fellows Fund (CGFFF) Award

In the face of dwindling funds that restrict trainee travel and exposure to important immunology education and leaders in the field, the CGFFF enables trainees and fellows to attend FOCIS Annual Meetings, educational courses, and participate in exchange programs. Award recipients receive a $500 reimbursement of travel expenses related to their FOCIS Annual Meeting participation.

Rosado Sanchez Isaac

2022 Recipient

Isaac Rosado-Sánchez, Ph.D.
The University of British Columbia. BC Children’s Hospital, Vancouver, Canada
Abstract (Immuno-engineering and Cellular Therapies)
Th39 – The Role of Chimeric Antigen Receptor (CAR) Versus Endogenous Co-stimulation in the Function of Alloantigen-specific Tregs

British Society for Immunology BSI 4

First Annual British Society for Immunology (BSI) Poster Prize Award

Together with FOCIS, BSI has established this prize recognizing the high quality of the recipient’s abstract submitted for presentation at the 22nd Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS 2022). The first annual BSI Poster Prize is given to a fellow or student. Award recipient receives up to £250 reimbursement of travel expenses related to their FOCIS Annual Meeting participation.

Ho Patrick lower res

2022 Recipient

Patrick Ho, PhD, University of California, San Francisco, California
Abstract (Immuno-engineering and Cellular Therapies)
Th50 – Elucidating Inflammation-induced Cell Fate Decisions in Primary Human Tregs

FOCIS2022 RectangleGraphic 369x301 01 1

FOCIS Research Award

This award is presented to FOCIS members who are presenting authors of abstracts accepted for oral presentation during the FOCIS Annual Meeting.

2022 Recipients

  1. Angela Gocher-Demske, PhD, University of Pittsburgh
    Interferon Gamma Induction of TH1-like Tregs Dampens Anti-viral Responses
  2. Bill Ruff,
    Repertoire Immune Medicines Understanding the T cell repertoire in autoimmune diseases using high-dimensional single-cell analysis of antigen-specific CD4+ and CD8+ T cells
  3. Carole Guillonneau, INSERM1064 CRTI University of Nantes
    Anti-CD45RC antibody immunotherapy prevents and treats experimental Autoimmune PolyEndocrinopathy Candidiasis Ectodermal Dystrophy syndrome
  4. Celestine Wanjalla, MD, PhD, Vanderbilt University Medical Center
    CGC+ CD4+ T cells are Cytomegalovirus specific cells that are biomarkers of cardiometabolic disease risk in persons with HIV
  5. Emilie Ronin, PhD, University of California, San Francisco
    Developing Islet Antigen-Specific Regulatory T Cell For Therapy in Type 1 Diabetes
  6. Enrica Calzoni, MD, PhD, Columbia University
    Reduced mTORC1 Signal in Autosomal Dominant Hyper-IgE Syndrome Can Be Partially Rescued with Addition of Exogenous Glutamine
  7. Fernando Alvarez, PhD, McGill University
    IL-33 and IL-4 synergize to dysregulate TREG cell function and promote type 2 responses in RSV-induced asthma
  8. Flore Castellan, PhD, The University of Tokyo
    Postnatal Depletion of Maternal Cells Shifts Splenic NK and CD8+ T-cell Profiles Toward Mature and Activated Phenotypes
  9. Garrett Dunlap, , Brigham and Women’s Hospital
    Detection and Clonal Dynamics of Alloreactive T Cells in a Kidney Transplant Recipient Experiencing Acute Rejection After Immune Checkpoint Inhibitor Therapy
  10. Hai Nguyen, PhD, Benaroya Research Institute
    Elucidating Inflammation-induced Cell Fate Decisions in Primary Human Tregs
  11. Jennifer Snyder-Cappione, PhD, Boston University
    Evidence of induction and sustained expression of autoantibodies six months after SARS-CoV-2 infection
  12. John Ray, PhD, Benaroya Research Institute
    Genome-wide prioritization of autoimmune disease-associated genetic variants in T cells identifies a risk variant that elicits effector T cell differentiation
  13. Kei Kishimoto, PhD, Selecta Biosciences
    Combination of ImmTOR tolerogenic nanoparticles and IL-2 mutein induces massive expansion of antigen-specific regulatory T cells
  14. Laura Passerini, , San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), San Raffaele Scientific Institute
    Tolerogenic Dendritic Cells Engineered with a Lentiviral Vector Encoding for IL-10 and Antigen Control T Cell Responses to Pathogenic Antigens
  15. Marketa Chlubnova, University of Oslo
    Phenotype-based isolation of antigen-specific CD4+ T cells in autoimmunity: A study of celiac disease
  16. Marta Mastrogiovanni, Institut Pasteur
    The Tumor Suppressor APC Regulates T Lymphocytes Migration: Insights from Familial Polyposis Patients
  17. Matt Alexander, MD, PhD, Vanderbilt University Medical Center
    The Minor Allele of a Single Nucleotide Polymorphism in SH2B3 Promotes CD8+ T Cell IFNg Production, Hypertension Development, and Renal Damage
  18. Mayra Cruz Tleugabulova, Genentech
    Notch2 regulates the homeostasis of lung interstitial macrophages
  19. Michael Paley, MD, PhD, Washington University
    Clonally Expanded CD8 T Cells Are Recruited to the CSF in Neurosarcoidosis Through the Chemokine Receptors CXCR3 and CXCR4
  20. Michelle Yu, MD, PhD, University of California, San Francisco
    Platelet activation through TRPC6 mediates Cystic Fibrosis lung inflammation and injury
  21. Miriam Fichtner, MD, Yale University
    Reemergence of Pathogenic B Cell Clones in Autoimmune Myasthenia Gravis Following B Cell Depletion Therapy
  22. Nathan Provin, MSc, Nantes Université
    Differentiation of Human iPSc into Functional Thymic Organoids for in vitro T Cell Generation and Cell Therapy
  23. Patrick Ho, PhD, University of California, San Francisco
    Elucidating Inflammation-induced Cell Fate Decisions in Primary Human Tregs
  24. Remi Creusot, PhD, Columbia University
    Preclinical Evaluation of a Precision Medicine Approach to DNA Vaccination in Type 1 Diabetes
  25. Remi Creusot, PhD, Columbia University
    Role of peptide modification and multivalent delivery on the efficacy and safety of peptide-based immunotherapy in Type 1 diabetes
  26. Ricardo Grieshaber-Bouyer, MD, Heidelberg University Hospital
    Inflammatory Responses Conserved Across Human and Murine Neutrophils
  27. S. Alice Long, PhD, Benaroya Research Institute
    Reduced CD8 T cell exhaustion in DR4 risk subjects is selectively augmented with abatacept in RA
  28. Sarah Crome, PhD, University Health Network and University of Toronto
    Regulation of allogeneic T cells by human group 2 and group 3 innate lymphoid cells and applications for cell therapy
  29. Stephanie Grebinoski, University of Pittsburgh
    Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3
  30. Susan DeWolf, MD, Memorial Sloan Kettering Cancer Center
    A New Lens into the Tissue-Specific Landscape of the T Cell Repertoire in Human Graft-Versus-Host-Disease
  31. Tho-Alfakar Al-Aubodah, BSc, McGill University
    Childhood Idiopathic Nephrotic Syndrome is Characterized by Antigen-Experienced B-Cell Responses and Diminished Immunoregulation that are Differentially Targeted by Distinct Immunosuppressive Treatments
  32. Tiffany Shi, Cincinnati Children’s Hospital Medical Center
    Renal Allograft Rejection: New Paradigms in T Cell Reactivity Revealed by Single Cell RNAseq Analysis
  33. Tobias Lanz, MD, Stanford University
    The B Cell Repertoire in Multiple Sclerosis Reveals Molecular Mimicry between EBV EBNA1 and GlialCAM
  34. Vamsee Mallajosyula, PhD, Stanford University
    Calibrating T Cell ‘Help’ by Antigen Cross-linking as a Universal Vaccine Platform Against Rapidly Evolving Pathogenic Viruses
  35. Víctor Sosa-Hernández, MD, MSc, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav)
    B cell subsets as severity-associated signatures in COVID-19 patients
  36. Yuki Muroyama, MD, PhD, University of Pennsylvania
    Induction of a T cell intrinsic DNA damage and repair response is associated with clinical response to PD-1 blockade.
FCE Centers of Excellence icon

FCE Award

This award recognizes trainees affiliated with an FCE, are FOCIS members, and submit an abstract to the FOCIS Annual Meeting. FCE Directors nominate their trainees for this award and the FCE Committee selects award recipients on a competitive basis.  Award recipients receive complimentary registration to the FOCIS Annual Meeting to present their research.

2022 Recipients

  1. Ada Sera Kurt, King’s College London FCE, UK
    Chimeric Antigen Receptor Regulatory T cells (CAR-Tregs) Provide Significantly Greater Modulation of Alloimmune Responses than Alternative Alloantigen-Specific Treg Strategies
  2. Ariadna Bartoló Ibars, UAB-Barcelona FCE, Spain
    Immunogenicity induced by full academic CD19 Chimeric Antigen Receptor (ARI0001) in patients recruited into the CART-BE-01 Clinical Trial
  3. Chad Poloni, BC Children’s Hospital FCE, Canada
    Allogenic and autologous stem cell transplant (SCT) recipients have detectable levels of SARS-CoV-2 antigen-specific T cells one month after mRNA vaccination
  4. Chiara Massa, Martin-Luther-Universität Halle-Wittenberg FCE, Germany
    Enhanced Function of Vaccine Dendritic Cells from Obese Donor upon Inhibition of Lipid Metabolism
  5. Cuelenaere-Bonizec Orianne, Clinical Investigation Center in Biotherapy (CIC BT) FCE, France
    The CDKN2A Deletion Influences the Establishment of the Tumor Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
  6. Dallin Dressman, Columbia University FCE,
    US Genotype-Phenotype Correlation of T Cell Subtypes Reveals Senescent and Cytotoxic Genes in Alzheimer’s Disease
  7. Emilie Ronin, UCSF FCE,
    Developing Islet Antigen-Specific Regulatory T Cell For Therapy in Type 1 Diabetes
  8. Garrett Dunlap, Brigham and Women’s Hospital FCE, US
    Detection and Clonal Dynamics of Alloreactive T Cells in a Kidney Transplant Recipient Experiencing Acute Rejection After Immune Checkpoint Inhibitor Therapy
  9. Hanane Touil, Columbia University FCE, US
    Developing trajectories of immunosenescence in diverse adults
  10. Isaac Rosado Sánchez, BC Children’s Hospital FCE, Canada
    The role of Chimeric Antigen Receptor (CAR) versus endogenous co-stimulation in the function of alloantigen-specific Tregs
  11. Janie ROBERT, Centre for translational systems immunology FCE, Uruguay
    IL-2 self-sufficient enhanced Tregs
  12. John Pell, Yale University FCE, US
    Bac Transgenic Overexpression Mice Recapitulate the Immunologic Role of Exonic Variants of APOL1
  13. Kelsey Voss, Vanderbilt FCE,
    Dysregulated Transferrin Receptor Disrupts T Cell Iron Homeostasis to Drive Inflammation in Systemic Lupus Erythematosus
  14. Lauren Walker, Vanderbilt FCE,
    US High-Throughput B Cell Epitope Determination by Next-Generation Sequencing
  15. Lina Petersone, UCL Institute of Immunity and Transplantation (IIT) FCE, UK
    IL-21 is a Key Regulator of Chronic Germinal Centers in Autoimmune Settings
  16. Marieke de Korte, Toronto Human Immunology Network FCE, Canada
    Natural Killer Cells may be Functionally Altered due to Simulated Microgravity Exposure
  17. Markéta Chlubnová, UiO FOCIS Center of Excellence, Norway
    Phenotype-based isolation of antigen-specific CD4+ T cells in autoimmunity: A study of celiac disease
  18. Miqdad Dhariwala, UCSF FCE,
    Commensal myeloid crosstalk in neonatal skin regulates long-term cutaneous type 17 inflammation.
  19. Nathalie Schmidt, UCL Institute of Immunity and Transplantation (IIT) FCE, UK
    Targeting cholesterol metabolism as a novel immune checkpoint in viral infections and cancer
  20. Nathan PROVIN, University of Nantes FCE, France
    Differentiation of Human iPSc into Functional Thymic Organoids for in vitro T Cell Generation and Cell Therapy
  21. Patrick Ho, UCSF FCE, US
    Elucidating Inflammation-induced Cell Fate Decisions in Primary Human Tregs
  22. Ricardo Grieshaber-Bouyer, Heidelberg University Hospital FCE, Germany
    Inflammatory Responses Conserved Across Human and Murine Neutrophils
  23. Sandra Romero-Ramirez, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán FCE, Mexico
    High salivary IgA-coating levels of the oral microbiota in patients with systemic lupus erythematosus (SLE)
  24. SAUL ARTEAGA CRUZ, Mexican Translational Immunology Group FCE, Mexico
    Long Term Expanded Purified Allospecific Tr1 Cells Maintain a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines and Express a Chemokine Receptor Profile Involved in Allograft Tolerance.
  25. Stephanie Grebinoski, University of Pittsburgh FCE, US
    Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3
  26. Tharshana STEPHEN, Institut Pasteur FCE, Paris, France
    IL-23 signaling induces autoimmune disease genes in Mucosal-associated invariant T (MAIT) cells